UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 10.538

Sortiert nach

Ipragliflozin, a sodium glucose co-transporter 2 inhibitor, reduces intrahepatic lipid content and abdominal visceral fat volume in patients with type 2 diabetes

Expert opinion on pharmacotherapy, 2017-09, Vol.18 (14), p.1433-1438

2017

Volltextzugriff (PDF)

iProMix: A Mixture Model for Studying the Function of ACE2 based on Bulk Proteogenomic Data

Journal of the American Statistical Association, 2023, Vol.118 (541), p.43-55

2023

Volltextzugriff (PDF)

Overlapping risk factors for diabetic ketoacidosis in patients with type 1 diabetes on ipragliflozin: case analysis of spontaneous reports in Japan from a pharmacovigilance safety database

Expert opinion on drug safety, 2023-08, Vol.ahead-of-print (ahead-of-print), p.1-10

2023

Volltextzugriff (PDF)

Effect of ipragliflozin on liver enzymes in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials

Expert opinion on pharmacotherapy, 2024-06, Vol.25 (7), p.925-935

2024

Volltextzugriff (PDF)

Real-World Evidence for Long-Term Safety and Effectiveness of Ipragliflozin in Japanese Patients with Type 2 Diabetes Mellitus: final Results of a 3-Year Post-Marketing Surveillance Study (STELLA-LONG TERM)

Expert opinion on pharmacotherapy, 2021-02, Vol.22 (3), p.373-387

2021

Volltextzugriff (PDF)

Real-world evidence for the safety of ipragliflozin in elderly Japanese patients with type 2 diabetes mellitus (STELLA-ELDER): final results of a post-marketing surveillance study

Expert opinion on pharmacotherapy, 2016-10, Vol.17 (15), p.1995-2003

2016

Volltextzugriff (PDF)

Facilitators and barriers to medication adherence in an HIV prevention study among men who have sex with men in the iPrEx study in Chiang Mai, Thailand

AIDS care, 2013-08, Vol.25 (8), p.961-967

2013

Volltextzugriff (PDF)

Intellectual Property Rights and Agricultural Development: Evidence from a Worldwide Index of IPRs in Agriculture (1961-2018)

The Journal of development studies, 2021-04, Vol.57 (4), p.650-668

2021

Volltextzugriff (PDF)

Exports vs. FDI under counterfeiting: implications for the IPR policy of an importing country

Applied economics letters, 2024-03, p.1-8

2024

Volltextzugriff (PDF)

Dissipation kinetics, safety evaluation, and decontamination of residues of the combo-formulation iprovalicarb 8.4% + copper oxychloride 40.6% WG in/on grapes (Vitis vinifera L.)

Journal of environmental science and health. Part B, Pesticides, food contaminants, and agricultural wastes, 2022-08, Vol.57 (8), p.670-679

2022

Volltextzugriff (PDF)

Validation of spectral simulation tools in the context of ipRGC-influenced light responses of building occupants

Journal of building performance simulation, 2023-03, Vol.16 (2), p.179-197

2023

Volltextzugriff (PDF)

Safety and efficacy of ipragliflozin in Japanese patients with type 2 diabetes in real-world clinical practice: interim results of the STELLA-LONG TERM post-marketing surveillance study

Expert opinion on pharmacotherapy, 2018-02, Vol.19 (3), p.189-201

2018

Volltextzugriff (PDF)

LH launchers for tokamaks at IPR

Radiation effects and defects in solids, 2024-07, Vol.179 (7-8), p.994-1008

Sharma, P. K.

2024

Volltextzugriff (PDF)

Seasonal variation in neurohormones, mood and sleep in patients with primary open angle glaucoma - implications of the ipRGC-system

Chronobiology international, 2021-10, Vol.38 (10), p.1421-1431

2021

Volltextzugriff (PDF)

Decolonizing Policy Research as Restorative Research Justice: Applying an Indigenous Policy Research Framework (IPRF)

Critical policy studies, 2024-04, Vol.18 (2), p.271-298

Ahmed, Binish

2024

Volltextzugriff (PDF)

Safety and effectiveness of ipragliflozin in elderly versus non-elderly Japanese type 2 diabetes mellitus patients: 12 month interim results of the STELLA-LONG TERM study

Current medical research and opinion, 2019-11, Vol.35 (11), p.1901-1910

2019

Volltextzugriff (PDF)

Endogenous IPR protection, commercial piracy, and welfare implications for anti-piracy laws

Applied economics letters, 2022-05, Vol.29 (8), p.718-722

2022

Volltextzugriff (PDF)

China's IPR regime and provincial patenting activity

Applied economics letters, 2022-07, Vol.29 (12), p.1139-1144

2022

Volltextzugriff (PDF)

Baseline characteristics and interim (3-month) efficacy and safety data from STELLA-LONG TERM, a long-term post-marketing surveillance study of ipragliflozin in Japanese patients with type 2 diabetes in real-world clinical practice

Expert opinion on pharmacotherapy, 2016-10, Vol.17 (15), p.1985-1994

2016

Volltextzugriff (PDF)

Probing the interaction of human serum albumin with iprodione, a fungicide: spectroscopic and molecular docking insight

Journal of biomolecular structure & dynamics, 2019-03, Vol.37 (4), p.857-862

2019

Volltextzugriff (PDF)

Safety and efficacy of ipragliflozin in elderly versus non-elderly Japanese patients with type 2 diabetes mellitus: a subgroup analysis of the STELLA-LONG TERM study

Expert opinion on pharmacotherapy, 2018-03, Vol.19 (4), p.327-336

2018

Volltextzugriff (PDF)

Protection of intellectual property rights (IPRs) and multinational firm boundaries: an examination of Korean firms' exports to affiliates

Asian journal of technology innovation, 2024-05, Vol.32 (2), p.246-273

2024

Volltextzugriff (PDF)

Safety of ipragliflozin in elderly Japanese patients with type 2 diabetes mellitus (STELLA-ELDER): Interim results of a post-marketing surveillance study

Expert opinion on pharmacotherapy, 2016-03, Vol.17 (4), p.463-471

2016

Volltextzugriff (PDF)

Therapeutic Effects of SGLT2 Inhibitor Ipragliflozin and Metformin on NASH in Type 2 Diabetic Mice

Endocrine research, 2020-04, Vol.45 (2), p.147-161

2020

Volltextzugriff (PDF)

Multi-residue analysis of captan, captafol, folpet, and iprodione in cereals using liquid chromatography with tandem mass spectrometry

Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment, 2019-11, Vol.36 (11), p.1688-1695

2019

Volltextzugriff (PDF)

1 – 25 von 10.538

Suche als RSS-Feed

Aktive Filter

SpracheChinesisch

SpracheDeutsch

KollektionTaylor & Francis Online

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(9.961)
Mit Volltextzugriff
(9.249)

Publikationsform

Sprache

8 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Taylor & Francis:Master (3349 titles)
(10.538)
Taylor & Francis
(10.035)
Taylor & Francis Journals Collection
(7.981)
IngentaConnect
(7.079)
IngentaConnect Journals
(6.584)
MEDLINE
(1.905)
JSTOR
(1.285)
EBSCOhost Business Source Ultimate
(1.215)
EBSCO_Psychology & Behavioral Sciences Collection
(1.168)
EZB Electronic Journals Library
(1.105)
Publisher website
(571)
Applied Social Sciences Index & Abstracts (ASSIA)
(552)
Worldwide Political Science Abstracts
(494)
Sociological Abstracts
(476)
Journals@Ovid Complete
(462)
PAIS Index
(433)
ERIC
(219)
Wiley Online Library - AutoHoldings Journals
(126)
SAGE Complete
(70)
International Bibliography of Art (IBA)
(60)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Ipragliflozin, a sodium glucose co-transporter 2 inhibitor, reduces intrahepatic lipid content and abdominal visceral fat volume in patients with type 2 diabetes

iProMix: A Mixture Model for Studying the Function of ACE2 based on Bulk Proteogenomic Data

Overlapping risk factors for diabetic ketoacidosis in patients with type 1 diabetes on ipragliflozin: case analysis of spontaneous reports in Japan from a pharmacovigilance safety database

Effect of ipragliflozin on liver enzymes in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials

Real-World Evidence for Long-Term Safety and Effectiveness of Ipragliflozin in Japanese Patients with Type 2 Diabetes Mellitus: final Results of a 3-Year Post-Marketing Surveillance Study (STELLA-LONG TERM)

Real-world evidence for the safety of ipragliflozin in elderly Japanese patients with type 2 diabetes mellitus (STELLA-ELDER): final results of a post-marketing surveillance study

Facilitators and barriers to medication adherence in an HIV prevention study among men who have sex with men in the iPrEx study in Chiang Mai, Thailand

Intellectual Property Rights and Agricultural Development: Evidence from a Worldwide Index of IPRs in Agriculture (1961-2018)

Exports vs. FDI under counterfeiting: implications for the IPR policy of an importing country

Dissipation kinetics, safety evaluation, and decontamination of residues of the combo-formulation iprovalicarb 8.4% + copper oxychloride 40.6% WG in/on grapes (Vitis vinifera L.)

Validation of spectral simulation tools in the context of ipRGC-influenced light responses of building occupants

Safety and efficacy of ipragliflozin in Japanese patients with type 2 diabetes in real-world clinical practice: interim results of the STELLA-LONG TERM post-marketing surveillance study

LH launchers for tokamaks at IPR

Seasonal variation in neurohormones, mood and sleep in patients with primary open angle glaucoma - implications of the ipRGC-system

Decolonizing Policy Research as Restorative Research Justice: Applying an Indigenous Policy Research Framework (IPRF)

Safety and effectiveness of ipragliflozin in elderly versus non-elderly Japanese type 2 diabetes mellitus patients: 12 month interim results of the STELLA-LONG TERM study

Endogenous IPR protection, commercial piracy, and welfare implications for anti-piracy laws

China's IPR regime and provincial patenting activity

Baseline characteristics and interim (3-month) efficacy and safety data from STELLA-LONG TERM, a long-term post-marketing surveillance study of ipragliflozin in Japanese patients with type 2 diabetes in real-world clinical practice

Probing the interaction of human serum albumin with iprodione, a fungicide: spectroscopic and molecular docking insight

Safety and efficacy of ipragliflozin in elderly versus non-elderly Japanese patients with type 2 diabetes mellitus: a subgroup analysis of the STELLA-LONG TERM study

Protection of intellectual property rights (IPRs) and multinational firm boundaries: an examination of Korean firms' exports to affiliates

Safety of ipragliflozin in elderly Japanese patients with type 2 diabetes mellitus (STELLA-ELDER): Interim results of a post-marketing surveillance study

Therapeutic Effects of SGLT2 Inhibitor Ipragliflozin and Metformin on NASH in Type 2 Diabetic Mice

Multi-residue analysis of captan, captafol, folpet, and iprodione in cereals using liquid chromatography with tandem mass spectrometry

Aktive Filter

Suchergebnisse filtern